For Licensed Providers
Give your patients real cellular repair.
Treating the core, not the symptoms. LathMized is the only NAD+ protocol proven to work intracellularly, with published results across 87+ biomarkers.
Most NAD+ products, IVs, and peptides stay extracellular. They treat the symptom. LathMized goes into the cell itself. No needles. No refrigeration. A powder that dissolves in water, swished in the mouth for 60-90 seconds, absorbed through the oral mucosa in under 4 minutes. Register to receive the full clinical deck.
A bioavailability approach designed for real results
Most NAD+ products, IVs, and peptides work extracellularly, addressing symptoms without reaching the source. LathMized is engineered to deliver NAD+ directly into the cell, where it's actually needed, with results you can measure.
+52.9%
Intracellular NAD+
increase observed
Within first 5 days*
100%
Subject response
rate in testing
All subjects showed increase*
87+
Biomarkers tracked
per patient
CLIA-certified testing
2 yr+
Molecule stability
shelf life
LathMized technology
Rapid Intracellular Support
Testing documented a 52.9% increase in intracellular NAD+ levels within the first five days of use. Designed for rapid cellular repletion directly where your patients need it most.
From Scoop to Cells in Minutes
500mg dissolves instantly in less than 4 ounces of water. Swished in the mouth for 60-90 seconds where it absorbs through the oral mucosa and bypasses the gut, then simply swallowed. No needles, no IV lines, no refrigeration.
Advanced Molecular Stability
Proprietary LathMized technology stabilizes the molecule for a 2+ year shelf life, addressing one of the primary challenges in NAD+ supplementation. No special storage, no cold chain, no complicated logistics.
Clinician-Guided Protocol
Every patient completes a consultation prior to use, ensuring the protocol is integrated into a professional, biometrically informed care plan. You remain in full control of the clinical relationship from start to finish.
All other NAD+ and peptides treat the symptom. We treat the core.
IVs, injectables, and most oral NAD+ products work extracellularly. They never fully reach the cell. LathMized delivers bioactive, bioavailable intracellular NAD, directly supporting the mitochondria where energy production and cellular repair actually happen. This is the difference between treating symptoms and treating the source.
*Based on internal testing data. Full clinical deck with methodology available upon registration.
Infected Surgical Wound
A 53-year-old female presented with a post-surgical wound that wouldn't heal due to a condition that prevents regular wound closure and was severely infected. Despite standard wound care, healing was stalled.
LathMized™ NAD⁺ introduced Day 1
LathMized™ NAD⁺ accelerated wound closure, reduced inflammation, and supported structural tissue regeneration. Healing progressed in 22 days, compared to the prolonged course expected under standard care alone.
Simple to order. Easy to offer.
You order directly from us, set your own retail pricing, and the product ships straight to your office. No middlemen, no complicated logistics, no cold chain.
1
Register
Register at the link below with your credentials. You'll automatically receive the clinical deck and our team will follow up to connect.
2
Order Direct
Place your order via a simple payment link. Product ships directly to your practice with a 2+ year shelf life. No refrigeration, no cold chain, no complications.
3
Offer to Patients
Set your own retail pricing and integrate the protocol into your practice. Each patient gets a doctor-directed experience you fully control.
What changes when cells have what they need.
As intracellular NAD+ levels are restored, patients consistently notice improvement across four areas. These shifts mark the transition from loading to maintenance dosing.
Sleep Quality
Often the first signal. As cellular repair processes begin functioning at optimal levels, patients experience more restorative sleep. This is one of the earliest and most consistent indicators that NAD+ levels are rising intracellularly.
Reduced Brain Fog
As intracellular NAD+ levels normalize, patients report cognitive clarity returning — sharper thinking, faster processing, and a notable reduction in mental fatigue throughout the day. Reduced brain fog is one of the most consistently reported outcomes during the loading phase.
Sustained Energy
Not a stimulant effect. The energy increase comes from cells generating ATP more efficiently at the mitochondrial level. Patients describe it as energy that is steady and lasting rather than the peaks and crashes of caffeine or other interventions.
Mental Execution
Beyond clarity, patients notice improved ability to follow through — better focus under pressure, improved working memory, and the capacity to stay mentally engaged for longer periods. Particularly notable in high-cognitive-demand patients.
Your patients are already asking.
Now you have the answer.
Register to receive the full clinical deck with testing methodology, biomarker data across 87+ markers, protocol details, and ordering information. Treating the core, not the symptoms, starts here.